Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterologous Prime-boost COVID-19 Vaccines in Mozambique and Madagascar
NCT04998240Phase 2Unknown
- Sponsor
- International Vaccine Institute
- Start
- Dec 2021
- Primary completion
- Sep 2022
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of BBIBP-CorV, Ad26.COV2.S in coronavirus disease 2019 (COVID-19), sponsored by International Vaccine Institute. Status: unknown.
02
Drugs
BBIBP-CorVAd26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04998240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04998240.